Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration

High-throughput ?omics? technologies that generate molecular profiles for biospecimens have been extensively used in preclinical studies to reveal molecular subtypes and elucidate the biological mechanisms of disease, and in retrospective studies on clinical specimens to develop mathematical models...

Descripción completa

Detalles Bibliográficos
Autores principales: McShane, Lisa M, Cavenagh, Margaret M, Lively, Tracy G, Eberhard, David A, Bigbee, William L, Williams, P Mickey, Mesirov, Jill P, Polley, Mei-Yin C, Kim, Kelly Y, Tricoli, James V, Taylor, Jeremy MG, Shuman, Deborah J, Simon, Richard M, Doroshow, James H, Conley, Barbara A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852338/
https://www.ncbi.nlm.nih.gov/pubmed/24228635
http://dx.doi.org/10.1186/1741-7015-11-220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852338/
https://www.ncbi.nlm.nih.gov/pubmed/24228635
http://dx.doi.org/10.1186/1741-7015-11-220

Ejemplares similares